Cage-like structures could enable selective separations in continuous-flow systems

Cement, ethanol, and ammonia makers are among those looking to convert waste carbon to cash

Lower-temperature process improves the efficiency of single-crystal solar cells

Lower-temperature process improves the efficiency of single-crystal solar cells

Reaction creates actinide 2-metallabiphenylenes

As the founder of multiple biotech firms, C&EN's guest editor has learned a thing or two about the challenges and triumphs of starting a company. We asked her to share her best advice for budding academic entrepreneurs

Lucy Therapeutics founder is taking an atypical approach to finding drugs for central nervous system diseases

Prolific biotech business founder says she's always on the lookout for problem-solving opportunities

The gene-editing tool CRISPR-Cas9 rerouted Doudna's career path. What hasn't changed for the renowned scientist and serial entrepreneur? Living and breathing the science

DRT brings sustainable fragrance ingredients and industrial additives

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun

Mechanically chiral rotaxane creates a catalytic pocket a little like an enzyme

Technique lets chemists control 3 variables independently and at micrometer resolution

Chemical companies prepare as the monolithic information technology platform known as ERP undergoes radical transformation

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost

Chemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply

Tearing and cutting lead to measurable debris from various forms of plastic

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun

Chemical makers, cleaning product firms, and cosmetics makers are all scrambling to meet new limits on the impurity

Useful when you don't have access to a sink and some soap, hand sanitizers have become a hot commodity in the face of COVID-19

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts

Activists say broad lack of enforcement threatens safety

Resources are freely available through April 17

With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap

Drugmakers want to keep trials going but acknowledge that medical resources are strained

Activists say broad lack of enforcement threatens safety

Study unravels reaction mechanism occurring on common catalyst

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

Phi and delta orbital interactions could improve nuclear waste management

Flexible approach involves coating complex objects with a variety of materials

The phenomenon behind the earliest photographs is making a comeback, inspiring new research in color printing and displays

Tests of 10 or more novel vaccines could be underway by mid-May

Members of the Division of Colloid and Surface Chemistry presented 155 virtual talks over 3 days

Flexible approach involves coating complex objects with a variety of materials